In this issue... PPP: what's new in the treatment, pathogenesis and terminology?
Michaëlsson
Gerd
G
Department of Medical Sciences/Dermatology and Venereology, University Hospital, Uppsala, Sweden.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy* / Q000209:etiology; D009626:Terminology as Topic
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab